0001209191-19-021598.txt : 20190328 0001209191-19-021598.hdr.sgml : 20190328 20190328145943 ACCESSION NUMBER: 0001209191-19-021598 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190328 FILED AS OF DATE: 20190328 DATE AS OF CHANGE: 20190328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carestio Daniel A CENTRAL INDEX KEY: 0001651806 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38848 FILM NUMBER: 19711545 MAIL ADDRESS: STREET 1: 5960 HEISLEY ROAD CITY: MENTOR STATE: OH ZIP: 44060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STERIS Ltd CENTRAL INDEX KEY: 0001757898 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 35312322454 MAIL ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-28 0 0001757898 STERIS Ltd STE 0001651806 Carestio Daniel A C/O 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2 IRELAND 0 1 0 0 Sr VP and Chief Operating Off Ordinary Shares 2019-03-28 4 A 0 20460 A 20460 D Employee Stock Option (right to buy) 53.52 2019-03-28 4 A 0 7000 A 2024-05-30 Ordinary Shares 7000 7000 D Employee Stock Option (right to buy) 67.98 2019-03-28 4 A 0 8000 A 2025-08-10 Ordinary Shares 8000 8000 D Employee Stock Option (right to buy) 69.72 2019-03-28 4 A 0 15000 A 2026-06-01 Ordinary Shares 15000 15000 D Employee Stock Option (right to buy) 77.07 2019-03-28 4 A 0 18000 A 2027-05-30 Ordinary Shares 18000 18000 D Employee Stock Option (right to buy) 114.22 2019-03-28 4 A 0 29864 A 2028-05-31 Ordinary Shares 29864 29864 D Employee Stock Option (right to buy) 125.58 2019-03-28 4 A 0 9468 A 2028-10-01 Ordinary Shares 9468 9468 D 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. This option to purchase 7,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 7,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 18,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 29,864 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was received under the Scheme in exchange for an option to purchase 9,468 STERIS ordinary shares for $125.58 per share, subject to the same terms and conditions as the original Old STERIS stock option. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2019-03-28